These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 20062025)
21. Biotech venture capital--it's not too late to be early. Klausner A Nat Biotechnol; 2005 Apr; 23(4):417-8. PubMed ID: 15815662 [No Abstract] [Full Text] [Related]
22. How do you measure "success" in a biotechnology company? Greetham EM Nat Biotechnol; 1998 May; 16 Suppl():59-60. PubMed ID: 9591275 [No Abstract] [Full Text] [Related]
23. Intellectual property as a foundation for funding. Meltzer SL; Marks MS; McCormick JT Nat Biotechnol; 2002 Jul; 20 Suppl():BE47-50. PubMed ID: 12089588 [No Abstract] [Full Text] [Related]
24. Teva to acquire Chinese biogenerics manufacturer. Katsnelson A Nat Biotechnol; 2005 Jul; 23(7):765. PubMed ID: 16003343 [No Abstract] [Full Text] [Related]
26. Increasing number of companies found ineligible for SBIR funding. Bouchie A Nat Biotechnol; 2003 Oct; 21(10):1121-2. PubMed ID: 14520384 [No Abstract] [Full Text] [Related]
27. Auctioning the cure. Willyard C Nat Med; 2011 May; 17(5):528-30. PubMed ID: 21546960 [No Abstract] [Full Text] [Related]
28. A venture capital view of challenges, opportunities, and innovation in biomedical research. Ratcliffe LT Clin Pharmacol Ther; 2011 Feb; 89(2):174-6. PubMed ID: 21252935 [TBL] [Abstract][Full Text] [Related]
35. Pharmaceutical industry must take its medicine. Macilwain C Nature; 2011 Feb; 470(7333):141. PubMed ID: 21307893 [No Abstract] [Full Text] [Related]
36. Finding new life in health stocks. Armour LA Fortune; 1997 Sep; 136(6):289-90, 292, 294. PubMed ID: 10173398 [No Abstract] [Full Text] [Related]
37. China tightens IP protection, but concerns linger. Jia H Nat Biotechnol; 2009 Sep; 27(9):787-8. PubMed ID: 19741619 [No Abstract] [Full Text] [Related]
38. Big companies helped by safe harbour ruling. Frantz S Nat Rev Drug Discov; 2005 Jul; 4(7):525-6. PubMed ID: 16075481 [No Abstract] [Full Text] [Related]
39. Companies jostle for access to public markets. Bouchie A Nat Biotechnol; 2003 Dec; 21(12):1413-4. PubMed ID: 14647309 [No Abstract] [Full Text] [Related]